Injective Protocol, a Layer 1 blockchain, and South Korean digital asset custodian BDACS announced a pivotal partnership on October 20, 2026. This collaboration aims to integrate KRW1, Korea’s pioneering won-backed stablecoin, into the Injective ecosystem.
The move is set to establish a dedicated won-denominated settlement layer for real-world assets (RWAs) and tokenization, directly addressing a significant gap in the rapidly evolving South Korean digital asset market.
South Korean stablecoin market gets won-backed option
The memorandum of understanding (MOU) between the two entities signifies a strategic push into one of Asia’s most active digital finance landscapes. This initiative could offer Korean investors a streamlined, local-currency pathway into tokenized markets, reducing reliance on foreign-denominated stablecoins.
The broader implications for Injective’s native token, INJ, are also coming into focus, with some analysts beginning to eye a potential rise towards the $10 mark.
The newly integrated KRW1 stablecoin is meticulously designed, backed 1:1 by Korean won cash reserves held in escrow at Woori Bank, a major financial institution in South Korea. This structure provides a crucial layer of stability and trust for institutional participants. Furthermore, BDACS has implemented real-time verification of these reserves through banking APIs, moving beyond the traditional quarterly attestations and enhancing transparency.
This partnership arrives as South Korea’s digital asset market has demonstrated a pronounced preference for dollar-backed stablecoins. Data indicates that approximately 14.9 trillion won, roughly $10.4 billion, in net stablecoin outflows have left Korea’s five major exchanges for offshore platforms over 18 consecutive months since January 2025. This substantial outflow highlights a clear demand for domestic, won-denominated settlement options.
The introduction of the KRW1 stablecoin on Injective is a direct response to this market dynamic. It allows tokenized assets to be traded and settled without the need to first route through dollar stablecoins, thereby mitigating foreign exchange exposure for Korean institutions and investors. This could be a game-changer for retaining capital within the domestic market.
While the initial proof-of-concept for KRW1 concluded on the Avalanche network on September 18, 2025, in collaboration with Woori Bank, its integration with Injective marks a significant expansion. KRW1 has since broadened its reach to other blockchains, including Ethereum and BNB Chain, leveraging LayerZero’s OFT standard for cross-chain movement, underlining its interoperability.
Driving real-world asset tokenization on Injective
Injective Protocol has been aggressively expanding its ambitions within the real-world asset (RWA) space, and this BDACS partnership is a logical extension of that strategy. The network has already established notable collaborations with entities like POSCO International and LG CNS, further solidifying its presence in the South Korean market. This latest move also aligns seamlessly with the broader South Korean government’s push for won-denominated stablecoins.
The blockchain’s capabilities for RWA integration received a significant boost with its official SEC-registered transfer agent status secured on October 14, 2026. This compliance milestone positions Injective as a robust, compliant Layer-1 solution for institutional tokenization. It streamlines the process for traditional financial entities to bring assets onto the blockchain.
Recent activity underscores Injective’s growing influence in the RWA sector. The platform has already processed over $7.5 billion in RWA volume, with $1 billion in tokenized assets residing on its network. This robust engagement signals continued industry interest in tokenization initiatives and the platform’s expanding role.
The Korean government is actively working to finalize the Digital Asset Basic Act, which will provide the legal framework for won stablecoin issuance, by the end of 2026. The Bank of Korea has publicly advocated for traditional banks to play a central role in anchoring this emerging market. This regulatory clarity will be crucial for the widespread adoption and success of initiatives like KRW1.
Capital influx bolsters Injective ecosystem growth
The recent partnership with BDACS comes amidst a period of notable growth in on-chain capital flowing into the Injective ecosystem. This increasing activity suggests renewed investor confidence and heightened engagement across the network.
Concurrently, the stablecoin market cap associated with Injective has also seen a healthy rise, indicating a growing accumulation of capital within the network. Sustained transaction activity, fueled by new integrations like KRW1, will be key to demonstrating the enduring utility and long-term viability of Injective’s expanding ecosystem.
Globally, stablecoins continue to solidify their position as a critical settlement channel for on-chain finance. The total stablecoin supply reached a record $322 billion in May 2026, according to Allium. Leading financial institutions like Citi project this figure could soar to $1.9 trillion by 2030 in its base case scenario, underscoring the immense potential within this sector and Injective’s strategic positioning.
The BDACS partnership strategically taps into this burgeoning global market while also addressing specific regional needs. By offering a localized, compliant solution, Injective aims to capture a share of the significant capital currently flowing out of the Korean market. This domestic focus could prove to be a powerful differentiator.
INJ price outlook: Could $10 be next?
The expansion of Injective’s ecosystem, particularly through strategic partnerships like the one with BDACS, is inevitably strengthening the investment case for its native token, INJ. The successful integration and sustained usage of new settlement markets could significantly bolster demand for the token. As of October 16, 2026, INJ was trading at $8.71, having already advanced above its 50-day Exponential Moving Average (EMA) at $6.94.
This upward momentum suggests a bullish sentiment is building around INJ. Analysts noted on October 14, 2026, that the token was testing a bullish breakout near $8.2100, with projections indicating over 20% upside potential towards the $10 mark. This optimistic outlook was partly fueled by the recent SEC transfer agent registration, a compliance milestone that signals increased institutional readiness.
Market forecasts for INJ remain dynamic, but many point towards further gains. Injective started October 2026 at $7.411 and is predicted to finish the month at $10.835, with a maximum forecasted price of $9.514 and a minimum of $6.469 during October. Broader forecasts for 2026 range from a low of $6.50 to a high of $10.50, with $8.40 identified as the initial support level.
Achieving the $10 price target for INJ remains a conditional outlook, dependent on several key factors. Continued adoption of the Injective network, robust growth in its DeFi applications, and broader positive trends in the cryptocurrency market will be crucial.
While the BDACS partnership provides a strong fundamental driver, its full contribution to token demand will unfold over time as KRW1 gains traction and regulatory approvals are secured.
The token’s ability to maintain its recent gains, including breaking above a four-week range near $8.40 on October 16, 2026, and climbing 23% to 28% in 24 hours, showcases its responsiveness to positive news. However, the market remains volatile, and while the strategic expansion lays solid groundwork, consistent buyer momentum and real-world utility will ultimately dictate INJ’s trajectory toward or past the $10 threshold.
Broader implications for digital finance
The collaboration between Injective Protocol and BDACS extends beyond mere stablecoin integration; it represents a significant step in the global maturation of digital finance. By providing a compliant, localized integrating stablecoin solution for a major economy like South Korea, the partnership is helping bridge the gap between traditional finance and decentralized ecosystems.
This model could serve as a blueprint for other national currencies looking to establish their presence in tokenized markets.
Furthermore, the focus on real-world assets (RWAs) is indicative of a wider trend in the blockchain industry. As institutions increasingly seek to tokenize tangible and intangible assets, the demand for robust, compliant Layer-1 blockchains capable of handling these complex transactions will only grow. Injective’s proactive approach, combined with its recent SEC registration, positions it favorably in this evolving landscape.
The direct impact on capital flows is also noteworthy. The initiative to stem offshore stablecoin outflows from Korea addresses a real economic concern for the nation. If successful, it could foster greater domestic liquidity within the digital asset space, potentially stimulating innovation and investment within South Korea’s burgeoning Web3 sector.
This local impact could resonate globally, as other nations observe the benefits of localized stablecoin solutions.
Ultimately, the success of the Injective-BDACS partnership will depend on widespread institutional adoption and continued regulatory support in South Korea. The ongoing development of the Digital Asset Basic Act will be critical in shaping the operating environment for KRW1.
Should these factors align, this collaboration could mark a pivotal moment for both Injective Protocol and the broader integration of national currencies into the decentralized financial world.